title: Erlotinib-induced folliculitis decalvans.
authors.affiliation: Department of Dermatology, Dudley Group Hospitals NHS Foundation Trust, Dudley, West Midlands, UK. daniel.keith@UHBristol.nhs.uk.
authors.forename: D J
authors.initials: DJ
authors.lastname: Keith
authors.forename: D G
authors.initials: DG
authors.lastname: Stewart
mesh_terms: D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D000069347:Erlotinib Hydrochloride; D005499:Folliculitis / Q000139:chemically induced*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D005938:Glucocorticoids; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride